Remove 2023 Remove Pharmaceutical Companies Remove Pharmaceutical Manufacturing
article thumbnail

How CDMOs Can Help with Regulatory Challenges

Drug Patent Watch

Quality Documentation and Manufacturing Expertise CDMOs are experienced in generating high-quality documentation required for regulatory submissions and have extensive expertise in drug development and manufacturing. 2023, November 17). 2023, October 12). link] UPM Pharmaceuticals. UPM Pharmaceuticals.

article thumbnail

Asahi Kasei establishes life science division to streamline bioprocess operations for pharma sector

Express Pharma

In 2023, the company enhanced its Glenview, Illinois facility to meet the rising market need for fluid management systems and virus filtration technologies. Our bioprocess portfolio, including recently launched Planova FG1 and THESYS SCS and ACS Columns, has received strong feedback from customers, the company stated.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EU Urban Wastewater Treatment Directive may compromise EU medicine availability

European Pharmaceutical Review

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. per cent of global patents to almost 2 per cent.

article thumbnail

Understanding the Regulatory Environment in Japan for Generic Drug Development

Drug Patent Watch

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. Retrieved from [link] Japan Pharmaceutical Manufacturers Association.

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing.

article thumbnail

Technology innovation aiding process spectroscopy market growth

European Pharmaceutical Review

Innovations in the process spectroscopy market molecular spectroscopy accounted for the greatest share of the process spectroscopy market between 2023 to 2033″ The analysis found that molecular spectroscopy accounted for the greatest share of the process spectroscopy market between the 2023 to 2033 forecast period.